学术讲座

时   间：2024年7月12日下午15:00-16:30

参会地点：重庆医科大学图书馆5楼504会议室（袁家岗校区）

题   目：Personalized medicine in Stem cell transplantation

 

 

Moustapha Hassan，Professor of Transplantation Research at the Karolinska Institutet, Sweden.

Moustapha Hassan is currently Director of the Preclinical Laboratory at the Karolinska University Hospital–Huddinge, Sweden and Professor of Transplantation Research at the Karolinska Institutet, Sweden.

Prof. Hassan completed his M.Sc. in Medical Toxicology at Alexandra University, Egypt in 1974, and received his Doctoral Degree from Uppsala University, Sweden, in 1987. He was made Associate Professor of Experimental Oncology at the Karolinska Institutet in 1994 and became Professor of Experimental Hematology and Experimental Cancer Medicine in 2005. 1n 2013 he was appointed as a professor of transplantation research. His research focuses on personalized medicine, nanomedicine/theranostics and transplantation related complications. He is the inventor of liposomal busulfan. He is in the key coordinator position in EU and Sweden in pharmacological guided personalized treatment of conditioning regimen in connection with bone marrow transplantation since 1990s.

Moustapha Hassan教授现任瑞典卡罗琳斯卡医学院医院临床前实验室主任、瑞典卡罗琳斯卡医学院移植研究学教授。

Hassan教授于1974年在埃及Alexandra University获得医学毒理学硕士学位，于1987年在瑞典乌普萨拉大学获得博士学位。1994年于瑞典卡罗林斯卡医学院任实验肿瘤学副教授，2005年成为实验血液学和实验肿瘤医学教授。2013年，他被任命为移植研究学教授。

Hassan教授的主要研究方向为个体化医学、纳米医学/治疗学和骨髓移植相关并发症。同时，他是白消安脂质体的发明者，也是瑞典和欧洲骨髓移植相关药物个体化给药治疗方案的负责人，并在此领域内有近三十年的研究经验。

 

 

校科研处，药学院

2024年7月10日